12394686

Source:http://linkedlifedata.com/resource/pubmed/id/12394686

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0034037, umls-concept:C0035647, umls-concept:C0085957, umls-concept:C0206034, umls-concept:C0392756, umls-concept:C0442124, umls-concept:C0449258, umls-concept:C0920317, umls-concept:C1274040, umls-concept:C1336527, umls-concept:C1704324
pubmed:issue	5
pubmed:dateCreated	2002-10-23
pubmed:abstractText	We determine if intravesical bacillus Calmette-Guerin (BCG) reduces the risk of progression after transurethral resection to stage T2 disease or higher in patients with superficial (stage Ta, T1 or carcinoma in situ) bladder cancer.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/2U10 CA11488-31, http://linkedlifedata.com/resource/pubmed/grant/5U10 CA11488-32
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0376374
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/BCG Vaccine
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0022-5347
pubmed:author	pubmed-author:LammDonald LDL, pubmed-author:SylvesterRichard JRJ, pubmed-author:van der MEIJDENAdrian P MAP
pubmed:issnType	Print
pubmed:volume	168
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1964-70
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:12394686-Administration, Intravesical, pubmed-meshheading:12394686-BCG Vaccine, pubmed-meshheading:12394686-Carcinoma, Transitional Cell, pubmed-meshheading:12394686-Carcinoma in Situ, pubmed-meshheading:12394686-Disease Progression, pubmed-meshheading:12394686-Humans, pubmed-meshheading:12394686-Neoplasm Staging, pubmed-meshheading:12394686-Randomized Controlled Trials as Topic, pubmed-meshheading:12394686-Survival Rate, pubmed-meshheading:12394686-Urinary Bladder Neoplasms
pubmed:year	2002
pubmed:articleTitle	Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials.
pubmed:affiliation	European Organisation for Research and Treatment of Cancer Data Center, Brussels, Belgium.
pubmed:publicationType	Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Meta-Analysis